Continuing Education Episode!
Acute Normovolemic Hemodilution (ANH) has a weird-sounding name, but it’s a totally logical way to reduce red cell transfusions. Steve Frank shows us why.
Dr. Steve Frank
He USES It!
Dr. Steve Frank and his colleagues in the Bloodless Medicine Program at Johns Hopkins believe ANH is an underutilized strategy. He joins me today to share the details of how ANH works, and whether other facilities can implement it as a part of their overall Patient Blood Management Program.
Dr. Steve Frank
He USES It!
Dr. Steve Frank and his colleagues in the Bloodless Medicine Program at Johns Hopkins believe ANH is an underutilized strategy. He joins me today to share the details of how ANH works, and whether other facilities can implement it as a part of their overall Patient Blood Management Program.
About My Guest:
Dr. Steve Frank is a Professor in the Department of Anesthesiology and Critical Care Medicine at the Johns Hopkins Medical Institutions, where he specializes in anesthesia for vascular, thoracic, and transplant cases. He serves as Medical Director for the Johns Hopkins Health System Blood Management Program and he also directs the Center for Bloodless Medicine and Surgery, a program for patients who wish to avoid transfusion.
Dr. Frank’s recent work relates to clinical studies in the area of collection and analysis of transfusion data from electronic medical records and methods for using such data to improve practice. He is currently on the Editorial Board of the journal TRANSFUSION, and he has served on the Board of Directors for AABB and SABM. He is also Chair of the Committee on Patient Blood Management for the American Society of Anesthesiologists.
FREE Continuing Education!
This podcast episode offers a FREE continuing education activity where you can earn two different types of credit: 1 AMA PRA Category 1 CreditTM, or 1 ASCLS P.A.C.E.® Contact Hour (including Florida Clinical Laboratory Credit). This activity also may be used to fulfill Lifelong Learning Continuing Certification requirements for the American Board of Pathology.
To receive credit and review the accreditation information and related disclosures, please visit Transfusion News Continuing Education on Wiley Health Learning.
Please note: Continuing education credit is available for two years from the date this episode was released. In other words, you will no longer be able to claim credit for this episode after June 28, 2024.
DISCLAIMER: The opinions expressed on this episode are those of my guest and I alone, and do not reflect those of the organizations with which either of us is affiliated. Neither Dr. Frank nor I have any relevant financial disclosures.
Further Reading:
- Editorial by Dr. Frank and his group summarizing major issues in ANH: Grant MC, Resar LMS, and Frank SM. The Efficacy and Utility of Acute Normovolemic Hemodilution. Anesth Analg 2015;121(6):1412-1414.
Thanks to:
- Dr. Daniela Hermelin, Managing Editor; Follow Daniela on Twitter for fantastic #blooducation!
- Naomi Suguitan, BBGuy Assistant
Music Credit
Music for this episode includes “Cuando te invade el temor” and “Reflejo,” both by Mar Virtual via the Free Music Archive. Click the image below for permissions and license details.
Very interesting! If I’ve got this right, a major advantage of ANH over cell saver is that we’re replacing whole blood with whole blood whereas with cell saver we’re only replacing the red cells. As a result we avoid coagulopathies associated with loss of plasma and platelets.
For patients treated with cell saver, is there a returned volume of blood that once exceeded should prompt us to suspect impending dilutional coagulopathy?
Thanks!
Great discussion! Would you be able to advise on which collection bags you are using? We are having trouble finding bags for ANH collections.
Thanks !
Is sickle cell or thallasemia patients eligible for ANH?